Epizyme, Inc. v. GlaxoSmithKline LLC > Summary
Court Case Number IPR2020-00327
Filing Date Dec 19, 2019
Institution Decision Date Jun 15, 2020
Decision Date Oct 14, 2020
Court Patent Trial and Appeal Board
Status Final Written Decision
Administrative JudgesSheridan K. Snedden
Judge Writing the Final DecisionSheridan K. Snedden
Claims Challenged in the Petition: 1
Claims Instituted: 1
Petitioner
Patent Owner
Petitioner Attorneys
6Epizyme
Attorney Name: Edward R. Gates
Wolf, Greenfield & Sacks
Epizyme
Attorney Name: Richard F. Giunta
Wolf, Greenfield & Sacks
Epizyme
Attorney Name: Charles T. Steenburg
Wolf, Greenfield & Sacks
Epizyme
Attorney Name: Macaulay S. Rush
Wolf, Greenfield & Sacks
Epizyme
Attorney Name: Jonathan L. Sessler
Epizyme
Epizyme
Attorney Name: Izidore S. Lossos
Wolf, Greenfield & Sacks
Patent Owner Attorneys
7GlaxoSmithKline
Attorney Name: Dorothy P. Whelan
Fish & Richardson
GlaxoSmithKline
Attorney Name: Michael J. Kane
Fish & Richardson
GlaxoSmithKline
Attorney Name: Mark Rachlin
GlaxoSmithKline
GlaxoSmithKline
Attorney Name: Thomas D. Smith
GlaxoSmithKline
GlaxoSmithKline
Attorney Name: Gwilym J. O. Attwell
Fish & Richardson
GlaxoSmithKline
Attorney Name: Chad Shear
Fish & Richardson
GlaxoSmithKline
Attorney Name: Edward G. Faeth
Fish & Richardson
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 09562041 | Enhancer of zeste homolog 2 inhibitors | Feb 7, 2017 |
